Delivery Order SPE2DB20D2104-SPE2DB24FV41S

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,937.90, is a Firm Fixed Price Delivery Order for the supply of 60 tablets of 2 mg Risperidone, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of December 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is a $1,367.87 delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 1 mg tablets, a mental health medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,819.82 firm fixed-price delivery order is for the supply of 60 tablets of 1mg Risperidone, a medication used to treat mental health conditions. The contract has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,977.48, is for the delivery of Risperdal 4 mg tablets. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $2,879.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERDAL CONSTA 37.5 MG VIALS, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 15, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,508.01 firm fixed-price delivery order is for the supply of 500 tablets of 0.25 mg risperidone, a medication used to treat mental health conditions. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply Risperdal 4 mg tablets. The contract has a total ceiling value of $18,809.91 and a period of performance through October 25, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,092.81 firm fixed price delivery order is for the supply of Risperdal 0.5 mg tablets. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide...
This federal contract award is a delivery order with a firm fixed price valued at $1,836.79, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of 4568618256 - RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a firm fixed price valued at $19,767.46. The contract, awarded by the Defense Logistics Agency (DLA), provides for the delivery of risperidone 2 mg tablets to support military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV41S
    Delivery Order

This federal contract award, valued at $4,882.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product RISPERDAL 2 MG TABLET 60S, with an ultimate completion date of July 29, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award was not designated with a set-aside requirement, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 5/17/25, 9:51 AM